raloxifene hydrochloride has been researched along with Urogenital Prolapse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinkerton, JV; Stanczyk, FZ | 1 |
| Bain, C; Hagen, S; Ismail, SI | 1 |
2 review(s) available for raloxifene hydrochloride and Urogenital Prolapse
| Article | Year |
|---|---|
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
Topics: Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Meta-Analysis as Topic; Middle Aged; Pelvic Organ Prolapse; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2010 |